Holen Sie sich die Stockscreener-App
2.1999
1.86%
0.0499
Schlusskurs vom Vortag:
$2.15
Offen:
$2.22
24-Stunden-Volumen:
82,671
Relative Volume:
0.69
Marktkapitalisierung:
$9.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.23M
KGV:
-2.4087
EPS:
-0.9133
Netto-Cashflow:
$-10.29M
1W Leistung:
+11.73%
1M Leistung:
-45.93%
6M Leistung:
-78.41%
1J Leistung:
-79.29%
1-Tages-Spanne:
$2.15
$2.25
1-Wochen-Bereich:
$1.83
$2.26
52-Wochen-Spanne:
$1.83
$42.92
Seastar Medical Holding Corp Stock (ICU) Company Profile
Firmenname
Seastar Medical Holding Corp
Sektor
Branche
Telefon
844-427-8100
Adresse
3513 BRIGHTON BLVD, DENVER
Vergleichen Sie ICU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ICU | 2.1899 | 9.82M | 0 | -26.23M | -10.29M | -0.9133 |
| VRTX | 449.69 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.75 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.46 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.89 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.52 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Seastar Medical Holding Corp Aktie (ICU) Neueste Nachrichten
SeaStar Medical chief medical officer purchases $8,457 in stock - Investing.com
Seastar Soars On Latest Tidings - MENAFN.COM
SeaStar Soars on Latest Tidings - Baystreet.ca
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - Yahoo Finance
SeaStar Medical reports net revenue of USD 67,500 in Q3 2024 - Medical Buyer
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance
Half of Patients Now Enrolled in SeaStar Medical’s NEUTRALIZE-AKI Trial - MPO-mag
Critical Analysis: Merit Medical Systems (NASDAQ:MMSI) and SeaStar Medical (NASDAQ:ICU) - Defense World
SeaStar Medical (NASDAQ:ICU) Trading Down 3% – Here’s What Happened - Defense World
FDA grants breakthrough status to SeaStar Medical's SCD - Investing.com
FDA Grants Breakthrough Device Designation for SeaStar - GlobeNewswire
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis - Yahoo Finance
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial - GlobeNewswire
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - Yahoo Finance
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024Update - Yahoo Finance
SeaStar Medical Announces that Stanford Medicine is Cleared - GlobeNewswire
Seastar Medical settles dispute with Nuwellis for $900K - Investing.com
Seastar Medical settles dispute with Nuwellis for $900K By Investing.com - Investing.com UK
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers - GlobeNewswire
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark - Investing.com
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark By Investing.com - Investing.com South Africa
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis - GlobeNewswire
SeaStar Medical to Showcase New Mechanistic Data - GlobeNewswire
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire
SeaStar Medical expands trial sites for kidney injury device - Investing.com
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities - GlobeNewswire
SeaStar medical executive buys $4.3k in company stock By Investing.com - Investing.com Australia
SeaStar medical executive buys $4.3k in company stock - Investing.com
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial - GlobeNewswire
Seaport Entertainment Group Announces Commencement of Rights Offering - StockTitan
SEA (NYSE:SE) Shares Gap Up After Analyst Upgrade - Defense World
Sea Limited (NYSE:SE) Stake Decreased by HighVista Strategies LLC - Defense World
Sea Limited (NYSE:SE) Shares Sold by Itau Unibanco Holding S.A. - Defense World
Skandinaviska Enskilda Banken AB publ Has $4.09 Million Position in Sea Limited (NYSE:SE) - Defense World
SeaChange International (NASDAQ:SEAC) Coverage Initiated at StockNews.com - Defense World
Sea Limited (NYSE:SE) Shares Bought by Sei Investments Co. - Defense World
SEA (NYSE:SE) Hits New 1-Year High at $84.60 - Defense World
Why the Market Dipped But Sea Limited Sponsored ADR (SE) Gained Today - Yahoo Finance
SEA (NYSE:SE) Sets New 1-Year High at $84.60 - MarketBeat
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sea Limited stock soars to 52-week high of $85.16 By Investing.com - Investing.com Australia
Sea Limited stock soars to 52-week high of $85.16 - Investing.com
Parallel Advisors LLC Purchases 250 Shares of Sea Limited (NYSE:SE) - Defense World
Sea Limited (NYSE:SE) Receives $80.00 Average Target Price from Analysts - MarketBeat
Sea Limited (NYSE:SE) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Daiwa Securities Group Inc. Boosts Stake in Sea Limited (NYSE:SE) - Defense World
Ballentine Partners LLC Acquires Shares of 2,962 Sea Limited (NYSE:SE) - Defense World
Rhumbline Advisers Cuts Position in Sea Limited (NYSE:SE) - Defense World
SeaStar Medical (NASDAQ:ICU) Shares Up 5.5% - Defense World
FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit! - AccessWire
Finanzdaten der Seastar Medical Holding Corp-Aktie (ICU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Seastar Medical Holding Corp-Aktie (ICU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chung Kevin | Chief Medical Officer |
Sep 30 '24 |
Buy |
4.26 |
1,000 |
4,258 |
9,435 |
| Van Heel Kenneth | Director |
Nov 22 '23 |
Buy |
0.40 |
100,000 |
40,000 |
116,400 |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):